Discover why LeMaitre's expansion in the peripheral vascular disease market and strong dividend growth make it an appealing ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $95.25, a high ...

Lemaitre Vascular ( (LMAT) ) has released its Q3 earnings. Here is a breakdown of the information Lemaitre Vascular presented to its investors.

Lemaitre Vascular (LMAT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Daniel ...

LeMaitre Vascular has a 52-week low of $45.96 and a 52-week high of $101.67. LeMaitre Vascular ( NASDAQ:LMAT – Get Free Report ) last issued its earnings results on Thursday, October 31st.

LeMaitre Vascular had a return on equity of 13.39% and a net margin of 19.40%. The firm had revenue of $54.82 million for the quarter, compared to analyst estimates of $53.50 million.

Third Quarter 2024 Results Key Financial Results Revenue: US$54.8m (up 16% from ...

Welcome to the LeMaitre Vascular Q3 2024 Financial Results Conference Call. As a reminder, today's call is being recorded. At this time, I would like to turn the call over to Mr. J.J. Pellegrino ...

BURLINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- (Nasdaq:LMAT) announced today that management will be participating in ...

BURLINGTON, Mass. (AP) — BURLINGTON, Mass. (AP) — LeMaitre Vascular Inc. (LMAT) on Thursday reported third-quarter earnings of $11.1 million. On a per-share basis, the Burlington ...